Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023September 4, 2023 Avecho Biotechnology saw revenue from ordinary activities fall 41% to A$446k in the half year to […]
Company news: Rua Bioscience; IDT Australia; Emyria; Elixinol Wellness; Neurotech; Hygrovest; Releaf Group/ICCM; Botanix by Martin Lane August 30, 2023August 31, 2023
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 17, 2023
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023March 1, 2023
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022November 2, 2022
Company news: MediCann Health; Creso Pharma; Botanix Pharmaceuticals; Incannex by Martin Lane September 7, 2022August 16, 2023
Company news: Little Green Pharma; Live Verdure; Creso Pharma; Botanix by Steve Jones May 5, 2022May 5, 2022
Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex by Martin Lane February 2, 2022February 13, 2023
Company news: Zelira Therapeutics; Botanix Pharmaceuticals; Athena by Martin Lane September 30, 2021September 30, 2021
